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Executive Summary 
 
Drug misuse and particularly heroin abuse is a growing problem throughout Ireland. 
As a response Methadone Treatment is a well evaluated, cost-effective intervention 
which has been consistently shown to saves lives and improve the health and well-
being of patients who become dependent on heroin.  
 
The role and benefits of GPs providing treatment services to drug users is well 
documented. The Irish College of General Practitioners (ICGP) has played a central 
role in developing a protocol for the delivery of methadone treatment in primary care 
in the Irish context. Best Practice Guidelines for GPs have been published and GPs 
participating in the MTP have received training provided by the ICGP. 
 
This report carried out by the ICGP, outlines the results from a postal survey to all 
GPs on the ICGP Drugs Misuse Database. The questionnaire was designed to 
explore GP attitudes to the Methadone Treatment Protocol (MTP) and what 
additional services might support GPs in their work with opiate users. It also aimed to 
explore levels of satisfaction with training received and to assess whether any 
obstacles or barriers exist to taking patients on the MTP. 
 
 
Summary of Survey Results 
 
 
Out of the 600 questionnaires sent, 207 responses were received, giving a response 
rate of 34.5%. The majority of respondents (72%) already had patients on the MTP at 
that time while less than a third (28%) did not. 
 
 
GP attitudes to MTP 
 
Attitudes which focused on the benefits of methadone treatment suggest that GPs 
overwhelmingly believe that it is an essential service to drug users (95%), that it 
improves the health of patients (96%) and that it reduces criminality (96%). 
 
Furthermore the majority (96%) felt that the structure of the MTP provides a regular 
opportunity to review patient’s progress to allow a good relationship with the patient. 
 
 
Obstacles to taking on patients 
 
In general, very few obstacles to GPs taking on patients were identified. The most 
common response was that the GPs had not been asked to take on patients (30%). 
For GPs who already had patients on the MTP, 33% could see no obstacles to taking 
on more patients and of this group, 92% said they would be willing to take on more 
patients. Having reached the maximum numbers allowed was a reason given by 26% 
of respondents, while a further 16% stated that they felt they had enough patients 
already. There were 47 respondents (28%) who currently had no patients but were 
eligible to take patients on the MTP.  
 
These responses would suggest that there is an untapped willingness on the part 
GPs to be involved in the MTP.  
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Additional Support Services 
 
When asked what additional services would enhance the care they could provide for 
patients, 52% of respondents chose addiction counseling as their first choice. 
Inpatient detoxification beds were also a popular choice. 
 
 
Satisfaction with Training 
 
There was a high level of satisfaction with the training provided by the ICGP and 96% 
of respondents stated that it had adequately prepared them for managing a stable 
patient in primary care. Some respondents however felt that additional training was 
required in the management of patients who had co-existing alcohol or 
benzodiazepine problems. Making continuing medical education more accessible 
was another issue which was explored by the questionnaire. The existing format for 
CME, run by the ICGP for its general membership was seen as the preferred method 
of keeping appraised of new developments and a forum for discussion of problem 
cases. As a result of this survey, the ICGP has undertaken to review the current 
format for Level 1 and Level 2 training. 
 
 
 
Recommendations 
 
Based of the results of this survey, the ICGP can make the following 
recommendations to: 
 
• Inform the wider body of GPs of the high satisfaction levels amongst GPs 
currently participating in the MTP. 
• Inform the wider body of GPs on the evidence base surrounding the benefits 
of Methadone Treatment. 
• Explore methods to more fully utilise GPs who are willing to become involved 
with the methadone treatment programme. 
• Explore opportunities to transfer stable patients to GPs who have completed 
the training and are eligible to the take on patients. 
• Develop of Level 1 training to strengthen modules on working with people 
with continued illicit drug use, alcohol use and concurrent benzodiazepine 
problems.  
• Explore the feasibility of making addiction counselling services available to 
patients on the MTP particularly in the primary care setting  
• To train GPs on how to help patients come off Methadone if the patient 
wishes to. 
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Introduction 
 
Methadone in opiate dependency has been an internationally recognized treatment 
intervention for many years. It has a strong evidence base and two decades of 
randomised studies of methadone maintenance demonstrate consistent, positive 
results over vastly different cultural contexts. A number of comprehensive literature 
reviews support the benefits of methadone 1-4 including the National Treatment 
Outcome Research Study (NTORS), which monitored the progress of 1075 clients in 
the UK over five years5. The Farrell et al3 review of maintenance treatment in opiate 
dependence concludes that the major challenge in reducing the public health burden 
of opiate addiction is to deliver safe and effective maintenance treatment to as many 
people as will benefit from it. They recommended a community based approach 
where GPs prescribe methadone. They have shown that this results in significant 
improvements on a range of outcomes many of which affect the wider society as well 
as the drug user themselves. Clearly any support which will allow a methadone 
patient to live in, engage meaningfully and hopefully work in their community will 
have the best possible outcome. 
 
The benefits of substitute prescribing with methadone are: 
• Improvement in health and social functioning. 
• Reduction in opiate related deaths. 
• Reduction in illicit heroin use. 
• Better retention in treatment. 
• Reduction in criminal activity. 
• Reduction in transmission of HIV. 
• It is cost effective. 
 
These benefits are found consistently and are independent of the model of delivering 
methadone treatment. The literature also supports the view that if practitioners are 
properly trained, methadone maintenance can be effectively and safely delivered in a 
wide range of settings, including primary care. 
 
In the light of the strong evidence base for methadone as a treatment option, the 
ICGP wished to explore the attitudes of all GPs on the college drug misuse database 
of GPs who had attended for Substance Misuse Training.  A postal questionnaire 
was designed to explore attitudes to accepting patients and identify barriers if any to 
this process, given that one of the aims of the MTP is to move stable patients from 
treatment clinics back to primary care. Satisfaction levels with the MTP and how well 
the current training programme equipped GPs to manage their patients on 
methadone maintenance were also explored.  
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Background: The Methadone Treatment Programme in Ireland 
 
 
In January 1998 the Methadone Treatment Services Review was published by the 
Department of Health and Children. This report recommended a change in the 
regulation in how Methadone could be prescribed and dispensed. Based on the 
blueprint submitted by the ICGP, it also outlined a scheme for general practitioner 
involvement in treating patients on Methadone. The structure of the MTP allows for 
patients to be assessed, commenced on treatment and stabilised at a Health 
Services Executive (HSE) treatment centre or by a more experienced colleague 
(Level 2 GP).  The patients are usually referred back to their own G.P, for 
continuance of the maintenance script when they are stable on their methadone 
dose. Since the introduction of this protocol in October 1998, GPs from around the 
country have been participating in the Methadone Treatment Programme (MTP). The 
numbers of GPs participating in the scheme has been increasing steadily year by 
year: 247 GPs were participating in the MTP at the end of 2007.   
 
 
Table 1: Number of GPs on the programme in each region, and the number of 
patients involved*.  
 
GP Distribution 
 
Dublin Mid 
Leinster 
Dublin North 
East 
HSE 
West 
HSE 
South Total 
Total GP's 146 61 28 12 247 
Total 
Patients 1849 1015 91 92 3047 
 
 
 
Table 2: Number of patients for the period January 2007 – December 2007 in the 
same regions as above*.  
 
  
Total 
Patients  
HSE Dublin Mid Leinster 2067 
HSE Dublin North East 1177 
HSE West 107 
HSE South 99 
    
Totals 3450 
 
 
*Compiled by CTL 26 February 2008 
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GP Training  Requirements 
 
In order to participate in the MTP, a general practitioner must receive training in 
substance misuse and the management of opiate misusers and agree to regular 
audit. Regular training courses are provided by the ICGP throughout the year which 
are open to all GPs. Doctors completing their training in general practice should 
ideally have received Level 1 training before graduating from their training 
programme. There are currently two training programmes: 
 
Level One Training 
 
Level 1 training provides the foundation for treating stable methadone maintained 
patients in general practice. Having completed this training a GP may accept up to 
fifteen patients for methadone maintenance treatment in the primary care setting. 
Stabilisation usually takes place in a health board treatment centre but may also be 
offered by a suitably trained GP colleague (Level 2). Inter-referral between Level 1 
and Level 2 GPs is encouraged where this option is available. 
 
Level Two Training 
 
Before progressing to Level 2 training the following criteria must have been fulfilled 
by the GP: 
 
• The GP should have managed at least five patients on the MTP for a 
minimum of one year. 
• The GP should have successfully completed an external clinical audit 
conducted by the ICGP to ensure best practice at Level 1. 
 
Following the training which currently requires 13 clinical sessions supervised by a 
GP mentor, a Level 2 GP may initiate treatment, stabilise doses and provide ongoing 
maintenance treatment to a drug user in the primary care setting. A successful 
external Level 2 audit completes the accreditation process. 
 
Continuing Medical Education 
 
GP’s participating in the MTP are expected to engage in regular continuing medical 
education. In these sessions a wide range of issues relating to community based 
drug treatment are addressed and updates on guidelines or changes in practice are 
discussed. 
 
Annual Audit 
 
Regular audit is provided by an ICGP/HSE appointed audit nurse. The format for the 
audit is regularly updated and revised as appropriate. The range of care provided by 
the GP to his/her methadone patients is reviewed and referenced to the current best 
practice guidelines issued by the ICGP. 
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A Survey of Attitudes of GP’s to the Methadone Treatment 
Protocol 
 
In the light of the strong evidence base for methadone as a treatment option, the 
ICGP wished to explore the attitudes of all GPs on the ICGP drug misuse database. 
Doctors entered on this database have participated in Level 1 or Level 2 training, 
however, not all GP’s on the database were actively participating in the MTP at the 
time. The survey was designed to explore GP attitudes to accepting patients and to 
identify barriers if any to this process given that one of the aims of the MTP is to 
move stable patients from treatment clinics back to primary care. For GPs already 
participating, the survey explored satisfaction levels with the MTP and how well the 
current training programme equipped GPs to manage their patients on methadone 
maintenance.
Method 
 
In 2006, the ICGP undertook a survey of 
all GPs who were on the college drug 
misuse database. This database includes 
all GPs who at some stage have 
undergone training at Level 1 or Level 2 
through the ICGP Drug Misuse 
Programme. All GPs on the database 
were surveyed regardless of whether they 
had patients currently registered on the 
Central Treatment List. 
 
Response Rates 
 
There were 207 responses from 600 
questionnaires sent, giving a response 
rate of 34.5%. Reminder questionnaires 
were sent and a reminder notice was 
placed on the drug misuse section of the 
ICGP website. 
 
Results 
 
Profile of Respondents 
 
The majority of respondents were between 
35 and 60yrs. The remainder were equally 
divided between the younger group under 
35 age and an older over 60 years. (Table 
1) 
 
71% of respondents were male and 29% 
female. (Figure 1) 
 
The majority, 57%, of practices were 
described as being in urban areas with 
24% described as mixed urban/rural and 
9% as rural. (Table 2) 
 
Perception of Scale of Problem 
 
When asked how big a problem illicit drugs 
are in their practice, 42% felt there was a 
major problem in their practice area and 
15% felt it was a minor problem only. A 
further 42% felt that the problem was small 
or minimal. (Table 3) 
 
When perception of the scale of the 
problem was examined in reference to 
location, it was found that the majority of 
GPs who reported that illicit drugs were a 
major problem in their practice area were 
in an urban location (Table 2). The 
majority of GPs from rural areas reported 
little or minimal problems with illicit drug 
use in their practices.  
 
 
 
Table 1: Respondents Age Group 
 
Age N % 
<35 26 12.7 
36-45 54 26.3 
46-60 102 49.8 
>60 23 11.2 
Total 205 100 
 
 
Figure 1: Gender 
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Table 2: Practice Location 
 
Area N % 
Urban 136 66.3 
Rural 19 9.3 
Mixed 50 24.4 
Total 205 100 
 
 
Table 3: Scale of Problem 
 
Size of Problem N % 
Minor Problem 31 15.8 
A Little 43 21.8 
Minimal 40 20.3 
Major Problem 83 42.1 
Total 197 100 
 
Table 4: Location: Scale of Problem 
 
Size of Problem Urban Rural Mixed 
Minor Problem 21 4 6 
A Little 21 6 16 
Minimal 20 6 14 
Major Problem 67 2 14 
Total 128 18 50 
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Patients on Methadone Treatment 
 
72% of the respondents had patients on the methadone treatment protocol, while 28% did not (Figure 
2). Those who had patients on the protocol were asked how many patients they had. The responses 
are illustrated in Table 5 below. 
 
Figure 2             Table 5: Number of Patients 
72%
28%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Yes No
 
 
 
 
Obstacles 
 
GPs who were currently managing patients or the MTP were asked what obstacles there were to 
them taking on any patients.  The results are outlined in Table 6 
 
 
Table 6: Obstacles to taking on more patients; GPs who currently have patients 
 
Obstacles N % 
No obstacles 50 32.7 
Have reached protocol maximum 41 26.8 
Have enough already 25 16.3 
Never been asked to 25 16.3 
Practice staff don’t want any more 10 6.5 
Other patients don’t want more 2 1.4 
Total 153 100 
 
Of those who had responded that there were no obstacles to them taking on more patients, 92% said 
they would be willing to take on more patients, while 8% said they would not. 
 
GPs who were eligible to take on patients but who currently were not managing patients on the MTP 
were asked if there were any obstacles to them taking on any patients. The results are outlined in 
Tables 7 
 
Table 7: Obstacles to taking on any patients; GPs who currently have no patients 
 
Obstacles N % 
Other 35 32.1 
Never been asked to 33 30.3 
No demand in the area 19 17.4 
Fear of violence 10 9.2 
Fear it would put off private patients 10 9.2 
Practice too small 2 1.8 
Total 109 100 
Number of Patients N % 
1 – 10 59 55 
11 – 20 21 20 
21 – 30 6 5.6 
31 – 40 15 14 
50 3 2.7 
80 1 1.5 
100 1 1.5 
Total 107 100 
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Where ‘other’ was given as a response, respondents were asked to specify what other barriers they 
had encountered to taking on patients. The following areas were identified by two or more 
respondents: 
 
• Patients dropped out of programme or moved away from area. 
• Size/location of premises. 
• Inadequate back up. 
• Heroin abuse not a problem in the area. 
• Work load involved/ time constraints. 
• Lack of knowledge/training. 
• Personal reasons e.g. no empathy with addicts/not enjoyable work. 
• Other partners not keen. 
 
 
Attitudes to the Methadone Treatment Programme 
 
Respondents were asked to rate a number of statements with regard to the Methadone Treatment 
Programme on a scale from Strongly Agree to Strongly Disagree. The results are outlined in the 
Tables below. 
 
7A. Allows good relationship with 
patients 
  N % 
Strongly Agree 64 31.6 
Agree 127 62.8 
Disagree 10 5.1 
Strongly Disagree 1 0.5 
 
The majority of respondents agreed (62.8%) or 
strongly agreed (31.6%) that the MTP allows a 
good relationship with patients. Only a small 
number disagreed (5.1%) or strongly disagreed 
(0.5%) with this statement.  
 
 
7B. Provides regular opportunity to monitor 
progress with patients 
  N % 
Strongly Agree 75 37.1 
Agree 124 61.4 
Disagree     2 1 
Strongly Disagree    1 0.5 
The majority of respondents agreed (61.4%) or 
strongly agreed (37.1%) that the MTP provides 
regular opportunity to monitor progress with 
patients. A very small percentage disagreed 
(1%) or strongly disagreed (0.5%) with the 
statement.  
 
7C. Essential service for drug users 
  N % 
Strongly Agree 94 46.8 
Agree 97 48.2 
Disagree 8 4 
Strongly Disagree 2 1 
 
 
The majority of respondents either agreed 
(48.2%) or strongly agreed (46.8%) that the 
MTP is an essential service for drug users. A 
small number either disagreed (4%) or 
strongly disagreed (1%) with this statement. 
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7D. It is an overly rigid protocol 
  N % 
Strongly Agree 11 5.5 
Agree 28 14 
Disagree 14 73.6 
Strongly Disagree 14 6.9 
A small percentage of respondents either 
agreed (14%) or strongly agreed (5.5%) that it 
is an overly rigid protocol. However, the 
majority disagreed (73.6%) with this 
statement, with a small percentage strongly 
disagreeing (6.9%).  
 
 
 
 
 
 
 
 
 
 
 
 
 
7E. Eliminates chance of double 
scripting 
  N % 
Strongly Agree 54 26.9 
Agree 124 61.7 
Disagree 21 10.4 
Strongly Disagree 2 1 
 
 
The majority of respondents either agreed or 
strongly agreed that the MTP eliminates the 
chance of double scripting. Some disagreed 
with this statement (10.4%), while two people 
strongly disagreed (1%).  
7F. Improves health of patient 
  N % 
Strongly Agree 68 33.6 
Agree 127 62.9 
Disagree 7 3.5 
Strongly Disagree 0 0 
  
The majority (62.9%) agreed or strongly 
agreed (33.6%) that the MTP improves the 
health of the patient. A small percentage of 
respondents disagreed (3.5%) while none 
strongly disagreed with the statement.  
 
 
 
 
 
 
 
 
 
 
 
 
 
7G. Reduces criminality 
  N % 
Strongly Agree 66 32.7 
Agree 128 63.4 
Disagree 8 3.9 
Strongly Disagree 0 0 
 
 
Once again the majority agreed (63.4%) or 
strong agreed (32.7%) that the MTP reduces 
criminality. There were a small number who 
disagreed (3.9%) and none who disagreed 
strongly.  
 
 
7H. Supervised daily dispensing 
prevents patients from working 
 N % 
Strongly Agree 19 9.6 
Agree 81 40.9 
Disagree 94 47.5 
Strongly Disagree 4 2 
Opinions regarding this statement were 
divided. Just over half of respondents 
(50.5%) agreed or strongly agreed that 
supervised daily dispensing prevents patients 
from working, while just under half (49.5%) 
disagreed or strongly disagreed with the 
statement.  
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7I. It is difficult to get off Methadone 
  N % 
Strongly Agree 45 22.6 
Agree 119 59.8 
Disagree 34 17.1 
Strongly Disagree 1 0.5 
 
A strong majority either agreed (59.8%0 
or strongly agreed (22.6%) that it is 
difficult to get off Methadone. A smaller 
percentage either disagreed (17.1%) or 
strongly disagreed (0.5%) with the 
statement.  
 
7J. Keeps patients addicted to a substance 
  N % 
Strongly Agree 21 10.5 
Agree 105 52.8 
Disagree 66 33.2 
Strongly Disagree 7 3.5 
There was a more divided opinion 
regarding this statement. A majority 
(52.8%) agreed or strongly agreed 
(10.5%) that the MTP keeps patients 
addicted to a substance, while 33.2% 
either disagreed or strongly disagreed 
3.5%.   
 
 
Respondents were given the option to comment on the MTP at the end of the statement section. 
Other comments/suggestions given were: 
• Need a shorter waiting list. 
• Need a system for crisis intervention. 
• MTP a little too vigilant for long term patients/protocol should be more relaxed for clean and 
stable patients. 
• Little help to get patients off Methadone. 
• Impression is of long duration maintenance. 
• Allows time to grow and be decoupled from heroin if so desired. 
 
 
Training Attended 
 
Respondents were asked to indicate what level of training, if any, they had attended. Responses are 
illustrated in Figure 3 below. 
 
Figure 3: Level of Training 
7.8%
70.6%
21.6%
0.00% 20.00% 40.00% 60.00% 80.00% 100.00%
None
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Level 1 & 2
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Skills 
 
Those who had attended training were asked to rate a number of statements in order to ascertain 
whether they felt they had been provided with satisfactory skills to manage key areas. The results are 
outlined in the Figures below. 
 
Do you feel the training provided you with satisfactory skills to manage: 
 
Figure 4.1: Stable patients on methadone maintenance 
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The majority of respondents either strongly agreed (32%) or agreed (64.7%) that their training had 
provided them with satisfactory skills to manage stable patients on methadone maintenance. A small 
number (3.3%) disagreed. 
 
 
Figure 4.2: Patients who continue to use illicit drugs 
18
85
78
3
0 20 40 60 80 100 120 140 160 180
Strongly Agree
Agree
Disagree
Strongly Disagree
 
There was more divided opinion on this statement. A slight majority either agreed (46.2%) or strongly 
agreed (9.8%) that their training had provided them with satisfactory skills to manage patients who 
continue to use illicit drugs. However, 42.4% disagreed with this statement, while 1.6% strongly 
disagreed. 
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Figure 4.3: Complications of drug use 
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The majority of respondents either agreed (57.6%) or strongly agreed (8.7%) that their training had 
provided them with satisfactory skills to manage complications of drug use. A smaller percentage 
disagreed with this statement (32.1%) while a few people strongly disagreed (1.6%) 
 
Figure 4.4: Patients on the MTP with alcohol problems 
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As can be seen above, the majority of respondents either disagreed (62%) or strongly disagreed 
(1.6%) that their training had provided them with satisfactory skills to manage patients with alcohol 
problems. Some respondents felt they had the necessary skills, with 32.6% agreeing with the 
statement and 3.8% strongly agreeing. 
 
Figure 4.5: Patients on the MTP with benzodiazepines dependency 
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Similar to the previous statement regarding alcohol, a majority felt that they did not have the skills to 
manage patients with benzodiazepines dependency. A majority of 53.1% disagreed with the 
statement, while 1.6% strongly disagreed. There were some who felt they had the requisite skills, and 
40.4% agreed with the statement while 4.9% strongly agreed. 
 
Further Training 
 
Respondents were asked to rank (1, 2 and 3) which type of training would be most useful to them. 
Responses are outlined in Table 8 below. 
 
Table 8: Further Training 
  1st Choice 2nd Choice 3rd Choice 
Small CME Networks 78 (43%) 48 15 
Individual GP Tutor/Mentor 37 (18%) 45 21 
Distance Learning 35 (19%) 26 32 
Annual Conference 14 (8%) 22 37 
Drug Misuse Web Page 12 (7%) 17 24 
Annual Audit 4 (1.5%) 8 16 
Newsletter 2 (1%) 19 31 
 
The most popular first choice was small CME groups, next was distance learning and individual tutor, 
which were equally popular, followed by annual conference and a drug misuse website. 
 
Small CME networks were also the most popular second choice, followed closely by individual GP 
tutor. Distance learning and annual conference were the following two most popular choices. 
 
An annual conference was the most popular third choice, with distance learning and newsletter 
following closely.  
 
Additional Services 
 
Respondents were asked to rank (1, 2 and 3) which services they would choose to further enhance 
the services provided to their patients. The results are outlined in Table 9 below. 
 
Table 9: Additional Services 
  1st Choice 2nd Choice 3rd Choice 
Addiction Counselling 103 (52%) 33 27 
In-patient Detoxification Beds 50 (25%) 38 24 
Employment Schemes 17 (8.5%) 33 45 
In-patient Rehabilitation Service 14 (7%) 42 31 
Consultant Psychiatric Services 13 (6.5%) 22 22 
Drop-in/ Social Centres 2 (1%) 22 28 
 
The most popular first choice was addiction counselling, next was in-patient detoxification beds, 
followed by employment schemes and consultant psychiatric services. 
 
The most popular second choice was in-patient rehabilitation schemes, next was in-patient 
detoxification beds, followed by addiction counselling and employment services, which were equally 
popular. 
 
The most popular third choice was employment schemes, followed by in-patient rehabilitation service 
and drop-in/ social centres. 
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Comments/Suggestions 
 
Respondents were given an opportunity to record any comments or suggestions they had 
about the Methadone Treatment Programme. Comments received have been classified 
under a number of headings:  
 
Length of Time 
 
A number of respondents expressed concerns regarding the length of time patients stayed 
on methadone. Some are concerned about long term reliance.  
 
“I have patient stable for over 10 years….must still attend every 2 weeks, this is crazy!” 
 
Alternatives 
 
Some respondents suggested that alternatives such as buprenorphine should be available. 
One person suggested that “saliva sampling kits should be made available as urination is 
not supervised.” 
 
Communication 
 
It would appear that further communication is required, between GPs and with 
hospitals/registrars. One GP was not aware that a patient was on the MTP.  
 
Patient Support 
 
Some respondents identified the need for more support for patients. Rehabilitation, 
psychological counselling in the community, dedicated psychiatric services were all 
identified. Problems with current service structures were identified.  
 
“local psychiatric service won’t see patient with addiction, theyonly send them to drug 
associated counselling. Many patients say this puts them back to where drugs are being 
dealt”. 
 
GP Support 
 
Some GPs commented that they felt they did not have adequate support/information on the 
programme. More up to date information and guidelines on detox of stable patients were 
requested. A newsletter was suggested as a means of keeping up to date.  
 
“I would welcome guidance from more experienced GPs as practicals are fine but on the 
ground relationships etc tend to be more complex”. 
 
Training/Education 
 
Two respondents identified the need for more level 2 GPs in their areas. Others identified 
the need for more level 1 and level 2 GPs. The shortage of doctors prescribing methadone 
has led to long waiting lists, causing serious concerns.  
 
Some felt that there is a lack of ongoing training/education. One respondent commented 
that ”it would be beneficial to hold training outside of Dublin”.  
 
Another commented that “skills tend to fall off when not used enough therefore there is a 
need for ongoing training/education.” 
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Discussion 
 
 
This survey has been informative in exploring the attitudes of GPs who are already 
participating or who are eligible to participate in the Methadone Treatment Protocol. Ireland 
has developed a model of care for delivering methadone treatment which acknowledges the 
central role GPs play in delivering care. GPs who participate in the programme have a 
contract for service and agree to practice according to the ICGP Best Practice Guidelines.  
They also agree to have regular external audit which assesses the level of care they are 
providing to patients on methadone.  
 
Of the doctors who responded to the survey (72%) had patients currently on the MTP, and 
28% did not have patients. All GP’s who had participated in training and are therefore 
eligible to take on patients were surveyed so it is particularly important to know that 28% of 
trained GPs had no patients and to explore the reasons why this might be. 
 
 
GP attitudes to the MTP  
 
While there is an abundance of evidence to support the efficacy of methadone treatment, 
the survey explored the general attitudes of Irish GPs to methadone as a treatment option. 
Attitudes which focused on the benefits of methadone treatment suggest that GPs 
overwhelmingly believe that it is an essential service to drug users (95%), that it improves 
the health of patients (96%) and that it reduces criminality (96%). GPs also responded that it 
is more difficult to get off methadone (82%) and that it keeps patients addicted to a 
substance (63%). It is impossible to determine from these responses whether this is simply 
a statement of fact or whether these reflect a negative attitude to this aspect of methadone 
treatment. Overall however, the attitudes of doctors who already had MTP clients were very 
positive. 
 
With regard to the structure of the MTP, attitudes to some of our Best Practice Guidelines 
were explored. The guidelines recommend that patients are seen weekly, have a urine 
sample done weekly and have one methadone dose supervised in the pharmacy per week. 
The GP’s surveyed seemed very clear in their positive opinions regarding the ability to have 
a good relationship with the patients (94%) and that the structure of the programme allowed 
them to monitor the patients progress (98%). They did not agree that it was an overly rigid 
protocol (80%) however there was almost equal division on the question of daily dispensing 
and whether it might prevent patients from working (50.5%/49.5%). Daily dispensing is 
recommended during the initiation phase of the programme or during periods of instability 
and while it is no doubt “inconvenient” for the patient to attend the pharmacy daily, these 
recommendations are made in the interest of patient safety.  Once the patient stabilises the 
need for daily supervision diminishes and take away doses can be given safely to the 
patients. 
 
 
Obstacles to taking on patients 
 
GPs with patients currently on the MTP were asked if there were any obstacles to them 
taking on more patients. A third (33%) of GPs could see no obstacles to taking on more 
patients while a further 27% said they had reached the maximum numbers allowed under 
the MTP. Another group (16%) said they had not been asked to take on more patients. 
These responses indicate that there is significant scope for increasing the numbers of MTP 
patients in primary care if doctors were approached by the relevant agencies. The issue of 
increasing maximum numbers (15 patients for Level 1 and 35 for Level 2) allowed under the 
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terms of the MTP is currently being addressed and a mechanism for allowing GPs to apply 
to have additional numbers will be put in place.  Perceived obstacles such as fear of 
violence and fear that such patients may ‘put off’ private patients were not cited as a barrier 
amongst the majority of GPs.   This information can be encouraging for GPs who have yet to 
come for training and are perhaps wary of taking patients on. 
 
Of the respondents who were not willing to take additional patients 16% said they had 
enough patients already and 6% stated that the practice staff did not want any more.  
 
There were 47 respondents (28%) who had completed Level 1 Training and who were 
eligible to take patients on the MTP but who currently had no patients registered. In 
response to the question “what obstacles if any are there to you taking any patients” 30% of 
these respondents said they had not been asked and a further 17% felt there was currently 
no demand in their area to take patients. Again it would seem reasonable to conclude from 
these findings that most GPs who have presented for training have a willingness to 
participate in the programme if requested to do so or are referred back one of their own 
patients.  More active efforts could be made in encouraging or simply requesting GPs to 
manage their patients as there appears to be an untapped willingness to get involved.  A 
mechanism for regular communication between the GP Co-ordinators and treating GPs with 
regards to taking new patients could also prove effective. 
 
 
 
Satisfaction with Training 
 
The majority of respondents, 70% had received training to a Level 1 standard while 21% 
had progressed to Level 2 training. A small proportion of GPs stated that they had never 
received training even to Level 1 standard although they were listed on the ICGP database. 
One explanation for this could be that they were doctors who were actively treating patients 
at the time the MTP was introduced and were given a “grandfather” status at that time and 
exempted form the official training programme. 
 
Doctors were asked if the training had adequately equipped them to manage stable patients 
and the range of issues which arise frequently with MTP patients. At Level 1, GPs are 
trained to manage a stable patient on the programme and the majority (96%) agreed or 
strongly agreed about this. However when it came to dealing with problem patients, doctors 
were less satisfied with the training. 56% of GPs felt that the training provided them with the 
skills to manage patients who continued to use illicit drugs while 42% disagreed and 2% 
strongly disagreed. Similarly with the management of patients with complications of drug 
use 66% felt adequately skilled while the remainder did not. The majority of respondents 
(64%) either disagreed or strong agreed with the statement that the training had not 
provided them with the skills to deal with patients with alcohol problems on the MTP. 
 
In the management of MTP patients with a concurrent benzodiazepine problem, only 45% of 
the doctors felt the training had prepared them satisfactorily. Benzodiazepine use is a 
significant problem in the drug using population where some 70% of patients are known to 
take this medication along with their methadone Benzodiazepines are addictive, subject to 
abuse and diversion and should be prescribed with caution in drug misusers. It is essential 
that doctors have good guidelines on how to manage drug misusing patients with 
benzodiazepine problems and along with the guidelines issued by the Department of Health 
and Children, the training needs to focus clearly on this issue. 7 
 
The ICGP is currently reviewing the training programme for both Level 1 and Level 2 
training. The results of this survey will inform the review and appropriate changes will be 
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made in the training. Lack of training may lead to fear and prejudices, which in turn fosters 
negative responses towards this patient group.  
 
Maintaining skills and keeping appraised of current best practice is a requirement under the 
MTP GP contract. Continuing medical education (CME) is provided by the ICGP in Dublin 
where the majority of GPs are based. GPs were asked which CME format best suited their 
needs. The majority, 43% favoured a small CME group format which replicates the existing 
small group model which GPs participate in for other areas of practice. There was interest 
also in a distance learning format (19%) or an individual GP tutor/mentor (18%). In the U.K 
distance learning in the form of web pages and newsletters from the Royal College of 
General Practitioners are well used. Currently there are GP co-ordinators for each /HSE 
area with a National GP Co-ordinator for outside of Dublin who will provide advice and 
support to mange situations. The least popular form of CME is the audit which may seem 
threatening but is designed to be supportive to the GP by measuring progress and advising 
any ways to facilitate further improvements in their service. The feasibility of these options 
will be examined by the ICGP. 
 
A system of “shared care” has also been devised by the ICGP which allows for an in-
experienced GP to be mentored in managing an individual patient for a period of time.  This 
system has been very well received by GPs involved with it.  
 
 
Additional Support Services 
 
When asked what additional services would enhance the care they could provide for 
patients, 52% of respondents chose addiction counselling as their first choice. It is known 
that psycho-social interventions have a direct bearing on treatment outcomes8. While even 
low intervention methadone programmes (i.e. the provision of methadone without supportive 
services) has some positive effect, services which have good counselling and psychosocial 
support have much better outcomes.  
 
Inpatient detoxification was also a popular choice as an additional support. While both 
inpatient detoxification and inpatient rehabilitation undoubtedly have a role to play in 
recovery, the good outcomes from this form of intervention depends on careful patient 
selection. Inpatient treatment is considerably more expensive than treatment in the 
community however it has not been shown to more effective in terms of outcomes. While an 
in-patient admissions can sometimes be life saving, can interrupt a period of escalating use 
and are useful for medical reasons e.g. detoxification in pregnancy. Periods of treatment of 
3 months or less do not increase the persons chances of becoming abstinent.  Furthermore 
there is an increased risk of death from accidental overdose on discharge. In the face of 
such evidence there is at best a limited place for inpatient treatment. Families may have an 
unrealistic expectation of detoxification and many professionals who are not familiar with the 
success of maintenance treatment may be tempted to encourage this idea as the option of 
first choice.  
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Conclusion 
 
GPs are a key resource in the treatment of drug misuse. In addition, there are considerable 
advantages for treating opiate dependency with substitution treatment in the community by 
GPs. Patients can be seen close to where they live and the treatment can become part of 
their general medical care. To a large degree GPs have responded to the challenge of 
managing drug users and are recognised as an essential part of the drug misuse treatment 
services.  
 
It is encouraging that GPs view methadone treatment as being such a positive intervention 
for patients and that those participating in the MTP view it as a very positive experience 
overall. It is also encouraging that many GPs are willing to take additional numbers onto the 
programme if asked and similarly those without patients do not appear to have any major 
objections to taking patients on the programme. This information should assist GP Co-
ordinators and Level 2 doctors in placing stable patients with their own GP.  It is evident 
from this survey that with appropriate support and further education many more GPs might 
be stimulated into participating in the MTP. 
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